Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:396-404
Published online before print January 4, 2008, doi: 10.1161/CIRCULATIONAHA.107.727073
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/3/396    most recent
CIRCULATIONAHA.107.727073v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diwan, A.
Right arrow Articles by Dorn, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diwan, A.
Right arrow Articles by Dorn, G. W., II
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrowRelated Article

(Circulation. 2008;117:396-404.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation

Abhinav Diwan, MD; Janaka Wansapura, PhD; Faisal M. Syed, MD; Scot J. Matkovich, PhD; John N. Lorenz, PhD; Gerald W. Dorn, II, MD

From the Center for Molecular Cardiovascular Research (A.D., F.M.S., S.J.M., G.W.D.), Department of Pediatrics (G.W.D.), and Department of Molecular and Cellular Physiology (J.N.L.), University of Cincinnati; and Imaging Research Center, Department of Radiology, Children’s Hospital Medical Center (J.W.), Cincinnati, Ohio.

Correspondence to Gerald W. Dorn II, MD, Center for Molecular Cardiovascular Research, 231 Albert Sabin Way, ML 0839, Cincinnati, OH 45267-0839. E-mail dorngw{at}ucmail.uc.edu

Received July 10, 2007; accepted November 5, 2007.

Background— Pathological cardiac hypertrophy inevitably remodels, leading to functional decompensation. Although modulation of apoptosis-regulating genes occurs in cardiac hypertrophy, a causal role for programmed cardiomyocyte death in left ventricular (LV) remodeling has not been established.

Methods and Results— We targeted the gene for proapoptotic Nix, which is transcriptionally upregulated in pressure overload and Gq-dependent hypertrophies, in the mouse germ line or specifically in cardiomyocytes (knockout [KO]) and conditionally overexpressed it in the heart (transgenic [TG]). Conditional forced Nix expression acted synergistically with the prohypertrophic Gq transgene to increase cardiomyocyte apoptosis (0.8±0.1% in GqTG versus 7.8±0.6% in GqTG+NixTG; P<0.001), causing lethal cardiomyopathy with LV dilation and depressed systolic function (percent fractional shortening, 39±4 versus 23±4; P=0.042). In the reciprocal experiment, germ-line Nix ablation significantly reduced cardiomyocyte apoptosis (4.8±0.2% in GqTG+NixKO versus 8.4±0.5% in GqTG; P=0.001), which improved percent fractional shortening (43±3% versus 27±3%; P=0.017), attenuated LV remodeling, and largely prevented lethality in the Gq peripartum model of apoptotic cardiomyopathy. Cardiac-specific (Nkx2.5-Cre) Nix KO mice subjected to transverse aortic constriction developed significantly less LV dilation by echocardiography and magnetic resonance imaging, maintained concentric remodeling, and exhibited preserved LV ejection fraction (61±2% in transverse aortic constriction cardiac Nix KO versus 36±6% in transverse aortic constriction wild-type mice; P=0.003) at 9 weeks, with reduced cardiomyocyte apoptosis at day 4 (1.70±0.21% versus 2.73±0.35%; P=0.032).

Conclusions— Nix-induced cardiomyocyte apoptosis is a major determinant of adverse remodeling in pathological hypertrophies, a finding that suggests therapeutic value for apoptosis inhibition to prevent cardiomyopathic decompensation.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 331-332. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CJASNHome page
R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
D. E. Sosnovik, M. Nahrendorf, P. Panizzi, T. Matsui, E. Aikawa, G. Dai, L. Li, F. Reynolds, G. W. Dorn II, R. Weissleder, et al.
Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure
Circ Cardiovasc Imaging, November 1, 2009; 2(6): 468 - 475.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Sarwar and S. A. Cook
Genomic Analysis of Left Ventricular Remodeling
Circulation, August 4, 2009; 120(5): 437 - 444.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Szegezdi, D. C. MacDonald, T. Ni Chonghaile, S. Gupta, and A. Samali
Bcl-2 family on guard at the ER
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C941 - C953.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. W. Dorn II
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Cardiovasc Res, February 15, 2009; 81(3): 465 - 473.
[Abstract] [Full Text] [PDF]